Core Points - Jiangsu Provincial Market Supervision Administration imposed a total fine of 4.39 million yuan on Sichuan Xieli Pharmaceutical Co., Ltd. for violent resistance to an antitrust investigation related to raw materials [1][5] - The company reported a sales revenue of 349 million yuan in 2022, and the fine represents 0.8% of its sales [5] Company Overview - Sichuan Xieli Pharmaceutical, established in 1992, is a manufacturer of raw materials and intermediates, exporting to nearly 50 countries and regions including the EU, Eastern Europe, South America, and Southeast Asia [1] - Sichuan Difeite Pharmaceutical Co., Ltd., established in 1979, shares the same shareholders and legal representative as Sichuan Xieli Pharmaceutical [1] Investigation Details - The investigation began on May 31 and November 30, 2023, with the latter involving violent resistance from employees during the inquiry [2] - Employees attempted to obstruct the investigation by physically confronting law enforcement and destroying evidence, including throwing a computer from the sixth floor [3][4] Legal Consequences - The actions of Sichuan Xieli Pharmaceutical and its employees were deemed severe, leading to administrative penalties including fines for the legal representative and several employees [1][5]
暴力抗拒原料药反垄断调查 四川协力制药及6人被处罚439万元
Zhong Guo Jing Ying Bao·2025-05-28 15:26